Showing results (41-50 of 808) with videos related to
Sort By:
Pageof 81
Journal of Hypertension|April 22, 2009
When should antihypertensive drug treatment be initiated and to what levels should systolic blood pressure be lowered? A critical reappraisalAlberto Zanchetti, Guido Grassi, Giuseppe ManciaJournal of Hypertension|July 10, 2010
Awareness and behaviour of European physicians in relation to microalbuminuria and organ damage: an ESH-endorsed surveyHermann Haller, Jan Menne, Giuseppe ManciaBlood Pressure|February 9, 2011
Cardiovascular consequences of poor compliance to antihypertensive therapyGuido Grassi, Gino Seravalle, Giuseppe ManciaSeminars in Cardiothoracic and Vascular Anesthesia|September 9, 2006
Background and treatment of metabolic syndrome: a therapeutic challengePieter A van Zwieten, Giuseppe ManciaAmerican Journal of Hypertension|December 4, 2003
Tolerability and treatment compliance with angiotensin II receptor antagonistsGiuseppe Mancia, Gino Seravalle, Guido GrassiJournal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|August 22, 2002
Systolic blood pressure: an underestimated cardiovascular risk factorGiuseppe Mancia, Gino Seravalle, Guido GrassiJournal of Hypertension|March 5, 2002
Twenty-four hour ambulatory blood pressure in the International Nifedipine GITS Study Intervention as a Goal in Hypertension Treatment (INSIGHT)Giuseppe Mancia, Stefano Omboni, Gianfranco Parati, et al.High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension|May 3, 2014
Role of the sympathetic nervous system in hypertension and hypertension-related cardiovascular diseaseGino Seravalle, Giuseppe Mancia, Guido GrassiEuropean Journal of Clinical Investigation|October 20, 2015
Sympathetic activation in cardiovascular disease: evidence, clinical impact and therapeutic implicationsGuido Grassi, Gino Seravalle, Giuseppe ManciaJournal of Hypertension|June 22, 2018
Perindopril 3.5 mg/amlodipine 2.5 mg versus renin-angiotensin system inhibitor monotherapy as first-line treatment in hypertension: a combined analysisStéphane Laurent, Giuseppe Mancia, Neil PoulterPageof 81